The Moodiesburn-based group, which makes collagen products for the food industry, said: “Based on current trends, sales volumes in 2017 are now expected to be approximately 10 per cent lower than previously anticipated, which will result in an under-utilisation of available capacity.”
Devro said this under-utilisation would also hit profit margins, and “consequently the board now expects underlying operating profit for 2017 to be lower than previous expectations”. The shares closed down 39.25p at 186.75p.
Devro warned last August that costs related to its US manufacturing operation would be higher than previously expected. The company said yesterday that actions were now being taken “to rebalance the use of capacity across our global manufacturing base”.